The DOI matches its Crossref record; 103 of the 114 references it cites were found in a registry or an index; 52 of the 97 sources its claims cite were checked for support.
Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review
Open accessAbstract
Background: Malignant-associated abdominal wall endometriosis (AWE) is a rare pathology, likely to occur in 1% of scar endometriosis. The objectives of this study were to update the evidence on tumor degeneration arising from AWE to notify about the clinical characteristics, the different treatments offered to patients and their outcomes. Methods: A comprehensive systematic review of the literature was conducted. PubMed, Embase and Cochrane Library databases were used. Prospero (ID number: CRD42024505274). Results: Out of the 152 studies identified, 63 were included, which involved 73 patients. The main signs and symptoms were a palpable abdominal mass (85.2%) and cyclic pelvic pain (60.6%). The size of the mass varied between 3 and 25 cm. Mean time interval from the first operation to onset of malignant transformation was 20 years. Most common cancerous histological types were clear cell and endometrioid subtypes. Most widely accepted treatment is the surgical resection of local lesions with wide margins combined with adjuvant chemotherapy. The prognosis for endometriosis-associated malignancy in abdominal wall scars is poor, with a five-year survival rate of around 40%. High rates of relapse have been reported. Conclusions: Endometrial implants in the abdominal wall should be considered as preventable complications of gynecological surgeries. Special attention should be paid to women with a history of cesarean section or uterine surgery.
Overview
CoChat Summary
## TL;DR
This systematic review compiled 73 cases from 63 studies of malignant transformation in abdominal wall endometriosis and found that the condition is rare but often diagnosed late, with a mean 20-year interval from first surgery to malignancy. The most common histology was clear cell carcinoma (52/73), and outcomes were poor with 37.9% relapse and 22.4% mortality among those followed.
## Key findings
- The review included 73 patients from 63 studies; the median age at malignant transformation diagnosis was 47 years (range 37–67).
- The mean interval from first surgery to malignant transformation was 19.9 years; the longest reported interval was 41 years.
- The most frequent malignant histology was clear cell carcinoma (52/73), followed by endometrioid adenocarcinoma (11/73).
- Among 58 patients with follow-up, 22/58 (37.9%) relapsed, 13/58 (22.4%) died of disease, and complete remission was achieved in 36/58 (62.1%).
- The authors report a 5-year survival rate around 40% for endometriosis-associated malignancy in abdominal wall scars.
## Methods
- Systematic review performed according to PRISMA 2020 and prospectively registered in PROSPERO (CRD42024505274).
- Searched PubMed, Embase, and Cochrane Library from March 1946 to March 2023; included studies in English and French with sufficient reporting data.
- Extracted clinical, imaging, treatment, follow-up, and outcome variables from eligible studies; descriptive statistics and group comparisons were performed in R and survival analysis with Kaplan–Meier methods.
## Limitations
- The authors state the main limitation was the rarity of the disease, leading to mostly case reports with heterogeneous information, which limited statistical analysis, meta-analysis, and subgroup variance analysis.
- Evident from the text: the evidence base is small and observational, with no randomized comparisons and missing data for some variables, so treatment-effect conclusions are weak.
- Evident from the text: the review is limited to English and French studies, which may have excluded relevant reports.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
34 Valid · 5 Not valid · 29 Not checked · 82 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In particular, atypical endometriosis was found as the precursor of endometrioid ovarian cancer and clear cell cancer in 15–32% of the cases [20,21,22].”
§ Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review > 4. Discussion
What the sources say
- Partly supportedcites [20] Kawahara, N., Miyake, R., Yamanaka, S., and Kobayashi, H. (2021). A Novel Predictive Tool for Discriminating Endometriosis Associated Ovarian Cancer from Ovarian Endometrioma: The R2 Predictive Index. Cancers, 13. sourceExperimental — accuracy not yet measured
The Simple Summary calls ovarian endometrioma a precancerous condition for endometriosis-associated ovarian cancer, and the Case Report describes endometrioid carcinoma within an endometrioma. Neither passage identifies atypical endometriosis as the precursor or gives the claimed 15–32% figure; searches for those terms found no supporting passage. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [21] Hitti, 1990, Clear cell carcinoma arising in extraovarian endometriosis: Report of three cases and review of the literature, Gynecol. Oncol. source
- Not checked — no full text of the sourcecites [22] Schnieber, 1986, Maligne Entartung einer extragenitalen Endometriose [Malignant transformation of extragenital endometriosis], Geburtshilfe Frauenheilkd source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Ovarian and/or pelvic endometriosis is associated with approximately 42% of endometrioid ovarian cancer [18,19,20,21].”
§ Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review > 4. Discussion
What the sources say
- Could not verifycites [18] Scholler, 2007, CA125 in ovarian cancer, Biomark. Med. sourceExperimental — accuracy not yet measured
The Introduction discusses ovarian cancer and the possible fallopian-tube origin of serous tumors, while the Conclusions references mention endometriosis in relation to CA125. Searches for endometrioid ovarian cancer, endometriosis, and 42% found no passage in our copy reporting the claimed association or percentage. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [19] Vergote, 2005, Port-site metastases after open laparoscopy: A study in 173 patients with advanced ovarian carcinoma, Int. J. Gynecol. Cancer source
- Partly supportedcites [20] Kawahara, N., Miyake, R., Yamanaka, S., and Kobayashi, H. (2021). A Novel Predictive Tool for Discriminating Endometriosis Associated Ovarian Cancer from Ovarian Endometrioma: The R2 Predictive Index. Cancers, 13. sourceExperimental — accuracy not yet measured
The Introduction links endometriosis in the pelvic peritoneum or ovaries to subsequent endometriosis-associated ovarian cancer, and the Case Report describes endometrioid carcinoma within an endometrioma. Neither passage establishes that approximately 42% of endometrioid ovarian cancers are associated with ovarian or pelvic endometriosis; a search for “42%” found no such estimate. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [21] Hitti, 1990, Clear cell carcinoma arising in extraovarian endometriosis: Report of three cases and review of the literature, Gynecol. Oncol. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, one-third of case reports in the literature of clear cell carcinoma arising in cesarean section scars were not associated with endometriosis near the tumor [24].”
§ Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review > 4. Discussion
What the sources say
- Supportedcites [24] Ferrandina, 2016, Endometriosis-associated clear cell carcinoma arising in caesarean section scar: A case report and review of the literature, World J. Surg. Oncol. source
The Discussion states that almost one third of clear cell carcinomas arising within caesarean-section scars were not associated with endometriosis foci (Table 1). It cautions that absent pathologically assessed foci do not rule out prior endometriosis, because some patients had suggestive symptoms or a history of excision. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It must be emphasized that 90% of malignant scar endometriosis have undergone previous gynecological procedures with endometrium exposure, including and not limited to cesarean sections, therefore making the translocation theory more plausible [31].”
§ Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review > 4. Discussion > 4.1. Plausible Theories
What the sources say
- Partly supportedcites [31] Bedell, 2020, Incisional carcinoma of Mullerian Origin: A case report and review of literature, Gynecol. Oncol. Rep. sourceExperimental — accuracy not yet measured
The Discussion > Origin reports that over 90% of patients with primary incisional carcinoma had undergone procedures with possible endometrial exposure and presents this as evidence for translocation. It does not establish that translocation is more plausible than another mechanism overall; it describes primary incisional carcinoma as the condition to be explained, not a competing theory. The cited figure also concerns patients with primary incisional carcinoma, rather than specifically malignant scar endometriosis. (LLM, conf=0.86)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Larger cohorts have shown an increased risk of cancer in women with endometriosis [18,34].”
§ Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review > 4. Discussion > 4.1. Plausible Theories
What the sources say
- Could not verifycites [18] Scholler, 2007, CA125 in ovarian cancer, Biomark. Med. sourceExperimental — accuracy not yet measured
The Introduction (page not provided) mentions endometriosis only as a benign condition associated with elevated CA125. A search for endometriosis and cancer risk found no passage reporting that larger cohorts observed increased cancer risk in women with endometriosis. (LLM, conf=0.76)
- Partly supportedcites [34] Lai, Y.L., Hsu, H.C., Kuo, K.T., Chen, Y.L., Chen, C.A., and Cheng, W.F. (2019). Clear Cell Carcinoma of the Abdominal Wall as a Rare Complication of General Obstetric and Gynecologic Surgeries: 15 Years of Experience at a Large Academic Institution. Int. J. Environ. Res. Public Health, 16. sourceExperimental — accuracy not yet measured
The Introduction reports that cancers arise in an estimated 1% of women with ovarian endometriosis, and the Discussion describes studies linking endometriosis to ovarian clear cell carcinoma. But this paper reports a six-patient case series, not a larger cohort, and does not present a cohort comparison showing increased cancer risk in women with endometriosis generally. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
71 more claims · 17 with their cited sources checked
Create a free account to see all 150 claims and to verify the 2 references still open.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 39
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review > Abstract
“The main signs and symptoms were a palpable abdominal mass (85.2%) and cyclic pelvic pain (60.6%).”
§ Malignancy in Abdominal Wall Endometriosis: Is There a Way to Avoid It? A Systematic Review > 3. Results > 3.3. Clinical Manifestation
“The primary symptoms of malignant transformation of abdominal wall included an abdominal nodule, mass, or lump (37.0%), abdominal or pelvic pain (37.0%) and/or both (19.2%) (Table 2).”
Citations
Cites
ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN
SAMPSON, J. A. (1925) · Archives of Surgery · doi:10.1001/archsurg.1925.01120100007001 · Cited by 765 · cited 1×
“He proposed three criteria for the diagnosis of malignancy arising from endometriosis: (1) demonstration of benign and neoplastic endometrial tissues in the tumor, (2) the histology being compatible with endometrial origin, and (3) with no other discoverable primary tumor sites [6].”
BackgroundSmolarz, B., Szyłło, K., & Romanowicz, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910554 · Cited by 560 · cited 2×
“Endometriosis is a common condition which is estimated to occur in about 10–15% in women of reproductive age [1].”
BackgroundMalignancy in Endometriosis: Frequency and Comparison of Ovarian and Extraovarian Types
Stern, R. C., Dash, R., Bentley, R. C., Snyder, M. J., Haney, A. F., & Robboy, S. J. (2001) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200104000-00004 · Cited by 403 · cited 1×
“Malignant transformation is an extremely rare condition, and it is estimated to occur in 0.7 to 1.5% of all cases of endometriosis [8].”
BackgroundInfluentialAbdominal wall endometriosis: a surgeon's perspective and review of 445 cases
Horton, J. D., DeZee, K. J., Ahnfeldt, E. P., & Wagner, M. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.07.035 · Cited by 391 · cited 1×
“The probability of developing endometriosis on an abdominal surgical scar is 0.03% to 1% [13,14].”
BackgroundInfluentialYamaguchi, K., Mandai, M., Toyokuni, S., Hamanishi, J., Higuchi, T., Takakura, K., & Fujii, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1614 · Cited by 324 · cited 2×
“Yamaguchi et al. demonstrated that endometriotic cysts have an abundance of free iron that is strongly associated with frequent DNA mutations and may play a crucial role in the malignant transformation to ovarian cancers [46].”
BackgroundMalignant changes in endometriosis.
Rb, S. (1953) · PubMed · Cited by 296
Extrapelvic Endometriosis: A Systematic Review
Andres, M. P., Arcoverde, F. V. L., Souza, C. C. C., Fernandes, L. F. C., Abrão, M. S., & Kho, R. M. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.10.004 · Cited by 276 · cited 1×
“Deep endometriosis (DE) found in extra-pelvic sites could also be explained by other theories such as the celomic metaplasia theory, the embryonic cell and lymphatic dissemination theory [3].”
BackgroundOvarian and extraovarian endometriosis-associated cancer
Modesitt, S. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02149-x · Cited by 242 · cited 1×
“The study by Modesitt et al. (2002) noted the presence of “transition points” in such tumors, where a benign endometriotic gland was observed blending with atypical and overtly malignant glands [16].”
BackgroundScholler, N., & Urban, N. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.4.513 · Cited by 220 · cited 3×
“…in advanced-stage ovarian cancer, where its value increases along with tumor size and is useful for predicting responses to chemotherapy, disease progression and recurrence, serum CA125 does not seem to be a valuable marker for the diagnosis of malignant transformation of endometriosis [18,34].”
BackgroundESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: An update
Forstner, R., Thomassin-Naggara, I., Cunha, T. M., Kinkel, K., Masselli, G., Kubik-Huch, R., Spencer, J. A., & Rockall, A. (2017) · European Radiology · doi:10.1007/s00330-016-4600-3 · Cited by 204 · cited 1×
“Kawahara et al. (2021) published a formula that estimates R2 values by incorporating CEA and tumor diameters as independent predictive factors for discriminating endometriosis ovarian cancer, from ovarian endometrioma [20,51].”
BackgroundIncisional endometriosis after cesarean section, episiotomy and other gynecologic procedures
Gunes, M., Kayikcioglu, F., Ozturkoglu, E., & Haberal, A. (2005) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2005.00322.x · Cited by 169 · cited 1×
“Furthermore, they note a theory of metaplasia in which scar endometriosis appears de novo [30].”
BackgroundEržen, M., Rakar, S., Klančar, B., & Syrjänen, K. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6382 · Cited by 160 · cited 1×
“Mainly studied in malignant ovarian endometriomas, clear cell carcinoma (50% overall survival rate) seems to be more aggressive than endometrioid carcinoma (78% overall survival rate) [61].”
BackgroundPARP Inhibitors in Ovarian Cancer
Mittica, G., Ghisoni, E., Giannone, G., Genta, S., Aglietta, M., Sapino, A., & Valabrega, G. (2018) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892813666180305165256 · Cited by 158 · cited 1×
“Resistance to platinum-based chemotherapy may explain the dark outcomes in malignant AWE, but it remains to be determined whether PARPis have a therapeutic place in recurrent malignant AWE [60].”
BackgroundAtypical Sites of Deeply Infiltrative Endometriosis: Clinical Characteristics and Imaging Findings
Chamié, L. P., Ribeiro, D. M. F. R., Tiferes, D. A., Macedo Neto, A. C. D., & Serafini, P. C. (2018) · Radiographics · doi:10.1148/rg.2018170093 · Cited by 156 · cited 2×
“Most patients are asymptomatic, but in some cases, they present with a variety of non-specific symptoms, which negatively affect their quality of life [4].”
BackgroundExperimental endometriosis in the human
Ridley, J. H., & Edwards, I. K. (1958) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(58)90011-5 · Cited by 139 · cited 1×
“They showed that the endometrium is viable in vivo [32].”
BackgroundPort-site metastases after open laparoscopy: A study in 173 patients with advanced ovarian carcinoma
Vergote, I., Marquette, S., Amant, F., Berteloot, P., & Neven, P. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.00135.x · Cited by 133
Hitti, I. F., Glasberg, S. S., & Lubicz, S. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90259-n · Cited by 129
Wang, P.-H., Yen, M.-S., Yuan, C.-C., Chao, K.-C., Ng, H.-T., Lee, W.-L., & Chao, H.-T. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4717 · Cited by 115
Malignant extraovarian endometriosis: A review
Benoit, L., Arnould, L., Cheynel, N., Diane, B., Causeret, S., Machado, A., Collin, F., Fraisse, J., & Cuisenier, J. (2006) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2005.08.011 · Cited by 108 · cited 1×
“Hyperestrogenism also seems to play a role [42].”
BackgroundEndometriosis-associated Malignancy
Krawczyk, N., Banys-Paluchowski, M., Schmidt, D., Ulrich, U., & Fehm, T. (2016) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0035-1558239 · Cited by 107 · cited 1×
“Endometriosis was significantly associated with an increased risk of clear cell, low-grade serous and endometrioid invasive cancers [35].”
BackgroundExtra-pelvic endometriosis: a review.
Hirata, T., Koga, K., & Osuga, Y. (2020) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12340 · Cited by 107 · cited 1×
“Endometriosis can affect the ovaries, the uterosacral ligaments and the peritoneal surfaces, and less frequently, it can spread to the bladder or extra-pelvic organs (intestine, abdominal wall, thoracic cavity) [2].”
BackgroundZhao, X., Lang, J., Leng, J., Liu, Z., Sun, D., & Zhu, L. (2005) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2005.05.007 · Cited by 106 · cited 1×
“For this, they suggest a 5 mm disease-free resection margin in AWE [55].”
BackgroundPrognostic analysis of ovarian cancer associated with endometriosis
Kumar, S., Munkarah, A., Arabi, H., Bandyopadhyay, S., Semaan, A., Hayek, K., Garg, G., Morris, R., & Ali-Fehmi, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.017 · Cited by 85 · cited 1×
“[62].”
A retrospective review of abdominal wall endometriosis in Shanghai, China.
Ding, Y., & Zhu, J. (2013) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.11.011 · Cited by 80 · cited 1×
“Ding et al. (2013) suggest minimum margins of 1 cm to avoid recurrence and malignant transformation, which may necessitate the resection of the fascia/muscle/peritoneum and the use of a mesh [56].”
BackgroundCarcinosarcoma arising from atypical endometriosis in a cesarean section scar
Leng, J., Lang, J., Guo, L., Li, H., & Liu, Z. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00199.x · Cited by 79
Bats, A. S., Zafrani, Y., Pautier, P., Duvillard, P., & Morice, P. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.080 · Cited by 77 · cited 1×
“Ad-ditionally, CT scan findings play a primary role in staging, as this imaging technique is more sensitive than ultrasound in detecting pelvic lymphadenopathy and is more able to assess distant thoracic metastases than MRI [52].”
BackgroundLeite, G. K. C., Carvalho, L. F. P. D., Korkes, H., Guazzelli, T. F., Kenj, G., & Viana, A. D. T. (2009) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802009000500005 · Cited by 75 · cited 1×
“For example, the uterus should not be exteriorized, exposure of endometrial mucosa during uterine suturing should be limited, different instruments should be used for uterine and abdominal closure, and peritonization may be advised [37].”
BackgroundFerrandina, G., Palluzzi, E., Fanfani, F., Gentileschi, S., Valentini, A. L., Mattoli, M. V., Pennacchia, I., Scambia, G., & Zannoni, G. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-1054-7 · Cited by 71 · cited 1×
“However, one-third of case reports in the literature of clear cell carcinoma arising in cesarean section scars were not associated with endometriosis near the tumor [24].”
BackgroundMiller, D., Schouls, J. J., & Ehlen, T. G. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.4989 · Cited by 68
Robinson, K. A., Menias, C. O., Chen, L., Schiappacasse, G., Shaaban, A. M., Caserta, M. P., Elsayes, K. M., VanBuren, W. M., & Bolan, C. W. (2020) · Abdominal Radiology · doi:10.1007/s00261-019-01914-7 · Cited by 67 · cited 2×
“Fibroblast growth factor (FGF-1) and interleukine 1 (IL1) are also expressed in both endometriosis and ovarian cancer, suggesting a common mechanism of action towards the malignant transformation [48].”
BackgroundAbdominal wall endometriosis: An 11-year retrospective observational cohort study
Marras, S., Pluchino, N., Petignat, P., Wenger, J.-M., Ris, F., Buchs, N. C., & Dubuisson, J. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology: X · doi:10.1016/j.eurox.2019.100096 · Cited by 63 · cited 3×
“This group was more likely to have experienced iatrogenic implantation of endometrial cells during surgery [33].”
BackgroundInfluentialShalin, S. C., Haws, A. L. F., Carter, D. G., & Zarrin‐Khameh, N. (2012) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2012.01982.x · Cited by 60
Transformation maligne d’une endométriose pariétale
Sergent, F., Baron, M., Le Cornec, J.-B., Scotté, M., Mace, P., & Marpeau, L. (2006) · Journal de Gynécologie Obstétrique et Biologie de la Reproduction · doi:10.1016/s0368-2315(06)76394-3 · Cited by 57
Mihailovici, A., Rottenstreich, M., Kovel, S., Wassermann, I., Smorgick, N., & Vaknin, Z. (2017) · Medicine · doi:10.1097/md.0000000000009136 · Cited by 56 · cited 2×
“The 5-year survival rate calculated by Mihailovici et al. (2017) is 40% with a median survival time after diagnosis of 42 months [9].”
BackgroundMethodImpact of endometriosis on risk of ovarian, endometrial and cervical cancers: A meta-analysis
li, J., Liu, R., Tang, S., Feng, F., Liu, C., Wang, L., Zhao, W., Zhang, T., Yao, Y., Wang, X., et al. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4968-1 · Cited by 56 · cited 1×
“The high iron content present in endometriotic lesions may also contribute to this excessive oxidative stress, which may favor the inductions of mutations [45,49].”
BackgroundEndometriosis-Associated Abdominal Wall Cancer
Taburiaux, L., Pluchino, N., Petignat, P., & Wenger, J.-M. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000556 · Cited by 55 · cited 3×
“These data endorse the idea that endometriosis can undergo malignant transformation rather than simply being a coexisting diagnosis, and that atypical endometriosis can be a precancerous state [17].”
BackgroundInfluentialPrimary abdominal wall clear cell carcinoma arising in a Caesarean section scar endometriosis
Alberto, V. O., Lynch, M., Labbei, F. N., & Jeffers, M. (2006) · Irish Journal of Medical Science · doi:10.1007/bf03169006 · Cited by 51 · cited 1×
“This raises the question whether estrogen therapy should be used concomitantly with a progestative agent in patients with residual endometriosis after menopause [43].”
BackgroundThe Endometriotic Tumor Microenvironment in Ovarian Cancer
Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51 · cited 2×
“The high iron content present in endometriotic lesions may also contribute to this excessive oxidative stress, which may favor the inductions of mutations [45,49].”
BackgroundClear cell carcinoma arising in a Cesarean section scar endometriosis: a case report
Park, S. W., Hong, S. M., Wu, H. G., & Ha, S. W. (1999) · Journal of Korean Medical Science · doi:10.3346/jkms.1999.14.2.217 · Cited by 50
Matter, M., Schneider, N., & McKee, T. (2003) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.07.003 · Cited by 47 · cited 1×
“It can be primary (umbilical endometriosis) or secondary (after trauma or surgery, known as scar endometriosis) and it is mainly found in incision scars and the umbilicus [12].”
BackgroundThe obstetrical history in patients with Pfannenstiel scar endometriomas--an analysis of 81 patients
Wicherek, L., Klimek, M., Skret-Magierlo, J., Czekierdowski, A., Banas, T., Popiela, T. J., Kraczkowski, J., Sikora, J., Oplawski, M., Nowak, A., et al. (2007) · Gynecologic and Obstetric Investigation · doi:10.1159/000096083 · Cited by 43 · cited 1×
“It is suggested that immunological tolerance during pregnancy might facilitate the implantation of decidual cells into the surgical wound [41].”
BackgroundMalignant transformation of an endometriotic lesion derived from an abdominal wall scar
Yan, Y., Li, L., Guo, J., Zheng, Y., & Liu, Q. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2011.06.018 · Cited by 42 · cited 3×
“The use of synthetic mesh or tissue transfer for wall closure is often necessary [47].”
BackgroundClear cell adenocarcinoma arising from umbilical endometriosis
Obata, K., Ikoma, N., Oomura, G., & Inoue, Y. (2013) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2012.01964.x · Cited by 40
Post-Cesarean scar endometriosis
Yıldırım, D., Tatar, C., Doğan, O., Hut, A., Dönmez, T., Akıncı, M., Toptaş, M., & Bayık, R. N. (2018) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.90922 · Cited by 39 · cited 1×
“The typical complaint of abdominal wall endometriosis is cyclic menstrual pain and a palpable mass [36].”
BackgroundMaligne Entartung einer extragenitalen Endometriose
Schnieber, D., & Wagner-Kolb, D. (1986) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-2008-1036277 · Cited by 37 · cited 1×
“In particular, atypical endometriosis was found as the precursor of endometrioid ovarian cancer and clear cell cancer in 15– 32% of the cases [20–22].”
BackgroundClear cell carcinoma arising in the abdominal wall: two case reports and literature review
Mert, İ., Semaan, A. Y., Kim, S. H., Ali‐Fehmi, R., & Morris, R. T. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.029 · Cited by 35
Mixed Clear Cell and Endometrioid Carcinoma Arising in Parietal Endometriosis
Razzouk, K., Roman, H., Chanavaz‐Lacheray, I., Scotté, M., Verspyck, É., & Marpeau, L. (2006) · Gynecologic and Obstetric Investigation · doi:10.1159/000096437 · Cited by 34
Endometrioid carcinoma arising in a scar of caesarean section. Case report.
Markopoulos, C. J., Gogas, H., Eleftheriou, G., & Floros, D. (1996) · PubMed · Cited by 34
Matsuo, K., Alonsozana, E. L. C., Eno, M. L., Rosenshein, N. B., & Im, D. D. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-0962-y · Cited by 32 · cited 1×
“…characterized as an “unstrained growth with increased neovascularization; unrestrained local and distant growth, metastasis; invasion into other tissues causing tissue damage; cytological and architectural atypia; resistance to apoptosis; and similar behavior to an estrogen-dependent neoplasm” [5].”
BackgroundClear Cell Carcinoma Arising in a Cesarean Section Scar
Ishida, G. M., Motoyama, T., Watanabe, T., & Emura, I. (2003) · Acta Cytologica · doi:10.1159/000326655 · Cited by 31 · cited 1×
“This may be explained by tumor destruction of normal tissue and endometriotic cells as they degenerate [26,27].”
BackgroundIsolated Clear Cell Adenocarcinoma in Scar Endometriosis Mimicking an Incisional Hernia
Harry, V. N., Shanbhag, S., Lyall, M., Narayansingh, G. V., & Parkin, D. E. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000260393.46154.5f · Cited by 30
Li, Q., Sun, Y., Zhang, X., Wang, L., Wu, W., Wu, M., Meng, C., & Liu, G. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1595278 · Cited by 30 · cited 1×
“Adjuvant chemotherapies were mostly taxane–carboplatin regimens, as this is the standard treatment for epithelial ovarian cancer, which was adapted to endometriosis-associated ovarian cancer [59].”
BackgroundMalignant transformation of abdominal wall endometriosis to clear cell carcinoma: case report
Gentile, J. K. D. A., Migliore, R., Kistenmacker, F. J. N., de Oliveira, M. M., Garcia, R. B., Bin, F. C., de Souza, P. M. S. B., & Assef, J. C. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2017.0103300417 · Cited by 29
Yoshimoto, C., Takahama, J., Iwabuchi, T., Uchikoshi, M., Shigetomi, H., & Kobayashi, H. (2016) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2016-0028 · Cited by 28 · cited 1×
“Restricted diffusion can be seen in both benign and malignant tumors [50].”
BackgroundIjichi, S., Mori, T., Suganuma, I., Yamamoto, T., Matsushima, H., Ito, F., Akiyama, M., Kusuki, I., & Kitawaki, J. (2014) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2014/642483 · Cited by 27 · cited 1×
“However, it remains unclear whether extensive resection is necessary as no malignant lesions were observed in the uterus or in both adnexa that were resected [57].”
BackgroundClear Cell Adenocarcinoma Arising from Abdominal Wall Endometriosis
Achach, T., Rammeh, S., Trabelsi, A., Ltaief, R., Ben Abdelkrim, S., Mokni, M., & Korbi, S. (2008) · Journal of Oncology · doi:10.1155/2008/478325 · Cited by 26
Exclusive nodal recurrence after treatment of degenerated parietal endometriosis
Bourdel, N., Durand, M., Gimbergues, P., Dauplat, J., & Canis, M. J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.004 · Cited by 26 · cited 1×
“Nevertheless, to exclude primary tumor sites and to establish the endometriotic origin, Bourdel et al. (2010) suggest radical tumor resection combined with bilateral adnexectomy and total hysterectomy or, at least, a sample of endometrial tissue collected by dilatation and curettage [58].”
BackgroundCesarean Section: A Potential and Forgotten Risk for Abdominal Wall Endometriosis
Ananias, P., Luenam, K., Melo, J. P., Jose, A. M., Yaqub, S., Turkistani, A., Shah, A., & Mohammed, L. (2021) · Cureus · doi:10.7759/cureus.17410 · Cited by 26 · cited 1×
“Some authors describe other prognostic factors such as the size of the mass at the time of diagnosis, which could play a role in a better outcome, especially if the masses range between 4 and 9 cm [63–74].”
BackgroundClear Cell Carcinoma in a Background of Endometriosis
Rust, M. M., Susa, J., Naylor, R. A., & Cavuoti, D. (2008) · Acta Cytologica · doi:10.1159/000325557 · Cited by 25
Da Ines, D., Bourdel, N., Charpy, C., Montoriol, P. F., Petitcolin, V., Canis, M., & Garcier, J.-M. (2011) · Acta Radiologica · doi:10.1258/ar.2011.100483 · Cited by 25
Liu, G., Wang, Y., Chen, Y., & Ren, F. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.08.006 · Cited by 25 · cited 1×
“The probability of developing endometriosis on an abdominal surgical scar is 0.03% to 1% [13,14].”
BackgroundInfluentialEndometroid carcinoma arising with a scar endometriosis.
Güçer, F., Reich, O., Kömetter, R., & Pieber, D. (1997) · PubMed · Cited by 24
Omranipour, R., & Najafi, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.065 · Cited by 23 · cited 1×
“The clinical context may be relevant, as some patients present with cyclic pain during menstruations, which strongly suggests the presence of endometriotic implants [28,29].”
BackgroundMarques, C., Silva, T. S., & Dias, M. F. (2017) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2017.03.008 · Cited by 22
Lai, Y.-L., Hsu, H.-C., Kuo, K.-T., Chen, Y.-L., Chen, C.-A., & Cheng, W.-F. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16040552 · Cited by 22 · cited 3×
“…in advanced-stage ovarian cancer, where its value increases along with tumor size and is useful for predicting responses to chemotherapy, disease progression and recurrence, serum CA125 does not seem to be a valuable marker for the diagnosis of malignant transformation of endometriosis [18,34].”
BackgroundGIANNELLA, L., SERRI, M., MACCARONI, E., DI GIUSEPPE, J., CARPINI, G. D., BERARDI, R., SOPRACORDEVOLE, F., & CIAVATTINI, A. (2020) · In Vivo · doi:10.21873/invivo.12021 · Cited by 22 · cited 1×
“Giannella et al. (2020) pointed out that in 58–64% of cases, there was an absence of a transition zone, making diagnosis even more difficult [25].”
BackgroundBahall, V., De Barry, L., & Rampersad, A. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02553-x · Cited by 22
Papillary Clear Cell Adenocarcinoma of the Groin Arising from Endometriosis
Klein, A. E., Bauer, T. W., Marks, K. E., & Belinson, J. L. (1999) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199904000-00025 · Cited by 20 · cited 1×
“This may be explained by tumor destruction of normal tissue and endometriotic cells as they degenerate [26,27].”
Background(2015) · Europe PMC (PubMed Central) · Cited by 20
Malignant transformation of abdominal wall endometriosis with lymph node metastasis
Fargas Fàbregas, F., Cusidó Guimferrer, M., Tresserra Casas, F., Baulies Caballero, S., & Fábregas Xauradó, R. (2014) · Gynecologic Oncology Case Reports · doi:10.1016/j.gynor.2013.12.003 · Cited by 19
Transformation of Abdominal Wall Endometriosis to Clear Cell Carcinoma
Ruiz, M. P., Wallace, D. L., & Connell, M. T. (2015) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2015/123740 · Cited by 19
Clear cell carcinoma arising from scar endometriosis: A case report and literature review
Huang, S.-H., & Wei, C.-J. (2017) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_11_17 · Cited by 19
Kawahara, N., Miyake, R., Yamanaka, S., & Kobayashi, H. (2021) · Cancers · doi:10.3390/cancers13153829 · Cited by 18 · cited 3×
“Kawahara et al. (2021) published a formula that estimates R2 values by incorporating CEA and tumor diameters as independent predictive factors for discriminating endometriosis ovarian cancer, from ovarian endometrioma [20,51].”
BackgroundLong-Term Follow-Up after Surgical Management for Atypical Endometriosis: A Series of Nine Cases
Tanase, Y., Kawaguchi, R., Uchiyama, T., & Kobayashi, H. (2019) · Case Reports in Oncology · doi:10.1159/000496178 · Cited by 16 · cited 1×
“Furthermore, Tanase et al. (2019) consider the following to be risk factors for malignant endometriosis: advanced age of the patient, postmenopausal status and tumor diameter of an endometriotic lesion larger than 9 cm [44].”
BackgroundMalignant transformation of endometriosis in a cesarean section abdominal wall scar: a case report.
Stevens, E., Pradhan, T. S., Chak, Y., & Lee, Y.-C. (2013) · PubMed · Cited by 15
Aust, S., Tiringer, D., Grimm, C., Stani, J., & Langer, M. (2015) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0619-0 · Cited by 14
Clear Cell Adenocarcinoma Arising From Abdominal Wall Endometriosis Mimicking Urachal Tumor
Sawazaki, H., Goto, H., Takao, N., Taki, Y., & Takeuchi, H. (2012) · Urology · doi:10.1016/j.urology.2011.02.034 · Cited by 14
Clear cell adenocarcinoma of the abdominal wall: a case report.
Heller, D. S., Houck, K. L., Lee, E. S., & Granick, M. S. (2014) · PubMed · Cited by 14
Port site endometrioma: a rare cause of abdominal wall pain following laparoscopic surgery
Siddiqui, Z. A., Husain, F., Siddiqui, Z., & Siddiqui, M. (2017) · BMJ Case Reports · doi:10.1136/bcr-2017-219291 · Cited by 14 · cited 1×
“Siddiqui et al. (2017) recommend extracting all tissues in an appropriate Endobag and deflating the pneumoperitoneum before removing the trocars [39].”
MethodAbdominal Wall Endometriosis Eleven Years After Cesarean Section: Case Report
Djaković, I., Vuković, A., Bolanča, I., Vraneš, H. S., & Kuna, K. (2017) · Acta Clinica Croatica · doi:10.20471/acc.2017.56.01.22 · Cited by 14 · cited 1×
“Malignant-associated abdominal wall endometriosis is likely to occur in 1% of such cases, particularly in cesarean section scars [15].”
BackgroundMixed endometrioid and clear cell carcinoma arising from laparoscopic trocar site endometriosis
Tsuruga, T., Hirata, T., Akiyama, I., Matsumoto, Y., Oda, K., Fujii, T., & Osuga, Y. (2019) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.14014 · Cited by 13
Drukała, Z., Ciborowska-Zielińska, B., Kubrak, J., & Rogowska, D. (2010) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2010.03.002 · Cited by 12
(2014) · PubMed · Cited by 12
Neamtu, R., Dahma, G., Mocanu, A. G., Bernad, E., Silaghi, C.-I., Stelea, L., Citu, C., Dobrescu, A., Bratosin, F., Grigoras, M. L., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052791 · Cited by 12 · cited 1×
“Some authors mentioned cases of AWE after supracervical hysterectomy, especially when no containment device was used [38].”
BackgroundPecorino, B., Laganà, A. S., Chiantera, V., Ferrara, M., Di Stefano, A. B., Di Donna, M. C., Sorrentino, F., Nappi, L., Mikuš, M., & Scollo, P. (2022) · Medicina · doi:10.3390/medicina58121706 · Cited by 12 · cited 2×
“…that for women with synchronous endometrial–ovarian endometrioid cancer affected by early-stage low-grade endometrioid cancer without apparent lymph node involvement at preoperative imaging have a very low rate of lymph node metastasis and similar relapse rate with or without lymphadenectomy [23].”
BackgroundRolon, M. D. M. R., Allen, D., Richardson, G., & Clement, C. G. (2019) · Case Reports in Pathology · doi:10.1155/2019/1695734 · Cited by 11
Clear cell carcinoma arising from abdominal wall endometrioma after cesarean section
Lopes, A., Antón, C., Slomovitz, B. M., de Mattos, L. A., & Carvalho, F. M. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000808 · Cited by 11
Malignant Transformation of Abdominal Wall Endometriosis: Case Report and Literature Review
Vinchant, M., Poncelet, C., Ziol, M., Vons, C., & Bricou, A. (2013) · Tumori Journal · doi:10.1177/030089161309900228 · Cited by 10
Incisional carcinoma of Mullerian Origin: A case report and review of literature
Bedell, S., Chang, Z., Burt, C., Khalifa, M. A., & Argenta, P. A. (2020) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2020.100588 · Cited by 10 · cited 4×
“This long interval is in favor of the translocation theory of benign endometriosis [31].”
BackgroundInfluentialComputer-Aided Diagnosis by Tissue Image Analysis as an Optical Biopsy in Hysteroscopy
Tanos, V., Neofytou, M., Tanos, P., Pattichis, C. S., & Pattichis, M. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112782 · Cited by 10 · cited 1×
“Further development of such techniques could be of great assistance in the early diagnosis and management of AWE [53,54].”
Self-citationClear Cell Carcinoma of the Anterior Abdominal Wall Secondary to Iatrogenic Endometriosis
Behbehani, S., Magtibay, P., Chen, L., & Wasson, M. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.12.016 · Cited by 9
Ji, W., Wu, J., Cheng, J., & Di, W. J. (2017) · PubMed · Cited by 9
Endometrioid Carcinoma Arising from an Endometriosis-Associated Abdominal Wall Scar
Paulino, E., de Melo, A. C., & da Silva, V. F. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.922973 · Cited by 8
Ferrari, F., Valenti, G., Forte, S., Ardighieri, L., Iraci Sareri, M., Barra, F., Sartori, E., & Odicino, F. (2021) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.14635 · Cited by 8
Malignant endometriosis of the abdominal wall.
Graur, F., Moiș, E. I., Elisei, R., Furcea, L., Dragota, M., Zaharie, T., & Hajjar, N. A. (2017) · PubMed · Cited by 7
Clear Cell Carcinoma Arising from Endometriosis in the Abdominal Wall
Castagnino, B., Angeramo, C. A., & Sadava, E. E. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-04992-5 · Cited by 7 · cited 1×
“The clinical context may be relevant, as some patients present with cyclic pain during menstruations, which strongly suggests the presence of endometriotic implants [28,29].”
BackgroundSurgery of abdominal wall endometriosis associated with clear-cell carcinoma: Case report and review
Petit, C., Donval, L., Chandeze, M.-M., Chis, C., Joste, M., & Panel, P. (2023) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2023.102561 · Cited by 7
Endometroid carcinoma developing in endometriosis over the symphysis pubis
Peer, M., Fellner, W., Seeber, B., Zeimet, A. G., & Marth, C. (2013) · Gynecologic Oncology Case Reports · doi:10.1016/j.gynor.2013.08.001 · Cited by 6 · cited 1×
“%) are localized in extra-gonadal sites like the small or large intestine, rectovaginal septum, abdominal wall, pleura, and others [9,10].”
BackgroundProvendier, A., Ángeles, M. A., Meyrignac, O., Illac, C., Ducassou, A., Martínez-Gómez, C., Gladieff, L., Martínez, A., & Ferron, G. (2020) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjaa070 · Cited by 6
Tanos, V., Tanos, P., & Georgiou, J. (2024) · Applied Sciences · doi:10.3390/app14020546 · Cited by 4 · cited 1×
“Further development of such techniques could be of great assistance in the early diagnosis and management of AWE [53,54].”
Self-citationLewis, G. K., Gajarawala, S. N., Robinson, K. E., Chen, A. H., & Robertson, M. W. (2022) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2022.100995 · Cited by 3
Malignant transformation of endometriosis in a laparoscopic trocar site a case report
Han, L. N., & Zhang, B. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01749-3 · Cited by 3 · cited 1×
“Some authors describe other prognostic factors such as the size of the mass at the time of diagnosis, which could play a role in a better outcome, especially if the masses range between 4 and 9 cm [63–74].”
BackgroundMolecular Analysis of an Abdominal Wall Cesarean Section Endometrioid Carcinoma
Karpathiou, G., Papoudou‐Bai, A., Zarkavelis, G., Picot, T., & Péoc’h, M. (2021) · International Journal of Surgical Pathology · doi:10.1177/10668969211018262 · Cited by 2
Cited by
Rectus Abdominis Muscle Endometriosis: A Unique Case Report with a Literature Review
Turčić, M., Matušan Ilijaš, K., Rajković Molek, K., & Valković Zujić, P. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47010047 · Cited by 6
“Immune cells, such as lymphocytes and monocytes/macrophages, play a significant role in immunomodulation and can either promote or inhibit the development of endometriosis, depending on their function.”
Primary Carcinomas of the Episiotomy Scar Site: A Systematic Literature Review
Palicelli, A., Torricelli, F., Tonni, G., Bisagni, A., Zanetti, E., Zanelli, M., Medina-Illueca, V. D., Melli, B., Zizzo, M., Morini, A., et al. (2025) · Current Oncology · doi:10.3390/curroncol32020065 · Cited by 7
“…(4.5% of extragonadal ERHs) and typically show estrogen receptors (ERs) downregulation with lack the immunohistochemical ER expression; moreover, mesonephric-like adenocarcinomas, a rare new entity which also downregulate ER and PR, can also exceptionally arise from endometriosis [69,73–84].”
InfluentialCo-existence of the abdominal wall and thoracic endometriosis: case report and literature review
Gao, B., Li, Z., Liu, H., Zhou, G., & Lai, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1578435 · Cited by 6
“%) at the surgical incision (17).”
Dayan, D., Wisniewski, L., Formentini, A., Kornmann, M., Bette, S., Ebner, F. K., Janni, W., Lukac, S., Traub, L., & Schochter, F. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03974-0 · Cited by 2
“The limited available evidence suggests a generally poor prognosis, with recurrence-free survival ranging from three to 93 months and a 5-year survival rate of approximately 40% [2, 29, 34].”
A Case of Clear Cell Carcinoma Associated with Abdominal Wall Endometriosis
艾, 日. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.42223
Metadata
- Authors
- Alaert, J., Lancelle, M., Timmermans, M., Tanos, P., Nisolle, M., & Karampelas, S.
- Affiliations
- Université Libre de Bruxelles (BE)
- University of Liège (BE)
- Corresponding author
- Tanos, Panayiotis
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2024-04-15
- Volume
- 13
- Issue
- 8
- Pages
- 2282
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC11050881
- OpenAlex
- W4394798567
- Cited by
- 9
- References
- 114
- Citations by year
- 2026: 4 · 2025: 5
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- abdominal wall endometriosis, endometriosis-associated malignancy, scar endometriosis, malignant transformation, adjuvant chemotherapy, surgical resection, prognosis, relapse, cesarean section complications, endometriotic implants
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
